Novartis AG
Lipids and lipid compositions for the delivery of active agents
Last updated:
Abstract:
This invention provides for a compound of formula (I): ##STR00001## or a pharmaceutically acceptable salt thereof, wherein R.sup.1-R.sup.4, L.sub.1, n and p are defined herein. The compounds of formula (X) and pharmaceutically acceptable salts thereof are cationic lipids useful in the delivery of biologically active agents to cells and tissues.
Status:
Grant
Type:
Utility
Filling date:
20 Jun 2018
Issue date:
2 Feb 2021